GEHA Ventures Invests in You Are Accountable to Expand Access to Post-Treatment Addiction Recovery Support
GEHA Ventures, the new venture capital arm of the Government Employees Health Association Inc. (GEHA), recently made its inaugural investment in You Are Accountable,...
Poppy Seed Tea Opioid Risks: What Clinicians and Patients Need to Know
Opioid addiction continues to be a critical public health issue, but one emerging concern many clinicians may overlook is poppy seed tea opioid risks....
Eleanor Appoints Healthcare Veteran William McKinney as CEO Amid Push for Value-Based Behavioral Health Innovation
Waltham, Massachusetts-based Eleanor, a hybrid mental health care and substance use disorder (SUD) provider, has announced the appointment of William McKinney as its new...
DEA’s Final Buprenorphine Rule: A Step Toward Expanding Telehealth Access for Opioid Use Disorder Treatment
Substance use disorder (SUD) treatment providers, particularly those focused on opioid use disorder (OUD), received significant news this week that could help expand access...
FTC Sues Substance Use Disorder Treatment Provider for Deceptive Advertising Practices
The Federal Trade Commission (FTC) has filed a lawsuit against Florida-based Evoke Wellness, accusing the substance use disorder (SUD) treatment provider of engaging in...
How Early Brain Development Affects Substance Use in Adolescence
Recent groundbreaking research has revealed that adolescents who engage in substance use exhibit different brain structures compared to their peers who do not use...
